{"schema_version":"secwatch.filing_event.v1","accession":"0001628908-26-000037","form_type":"8-K","ticker":"EVH","cik":"0001628908","company_name":"Evolent Health, Inc.","filed_at":"2026-06-04T20:05:16+00:00","discovered_at":"2026-06-04T20:06:00.289247+00:00","generated_at":"2026-06-04T20:07:40.706866+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Evolent Health shareholders elect 10 directors, approve incentive plan amendment at June 4 meeting","bullets":["All 10 director nominees elected with majority support; vote tallies range from 60.0M to 65.9M 'for' votes.","Advisory say-on-pay resolution approved 58.4M for vs 7.9M against (88% of votes cast).","Amendment to 2015 Omnibus Incentive Compensation Plan passed with 47.5M for, 18.7M against (71.8% of votes cast).","Ratification of Deloitte & Touche as auditor for FY2026 passed with 82.0M for, 0.1M against."],"urls":{"canonical":"https://secwatch.observer/filing/0001628908-26-000037","json":"https://secwatch.observer/filing/0001628908-26-000037.json","markdown":"https://secwatch.observer/filing/0001628908-26-000037.md","text":"https://secwatch.observer/filing/0001628908-26-000037.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/evh-20260604.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T20:07:40.706866+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"96c1f2c9d4822aec3201b68ee8335480743e1554","claim":"Evolent Health, Inc. shareholders approved Ratification of appointment of Deloitte & Touche LLP as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-04 meeting.","evidence_excerpt":"The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2026 as set forth below:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"c6ce3e851b04f98a1e37d64868c854e5ccde9929","claim":"Evolent Health, Inc. shareholders approved Election of ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the 2027 annual meeting at the 2026-06-04 meeting.","evidence_excerpt":"The Company’s stockholders elected ten director nominees named in the proxy statement to the Board of Directors for a one-year term expiring at the Company’s 2027 annual meeting of stockholders and until their respective successors are duly elected and qualified, as set forth below:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"cb3fd15e9ae43cbafeafcb1c80757244bd4087da","claim":"Evolent Health, Inc. shareholders approved Advisory approval of compensation of named executive officers for 2025 at the 2026-06-04 meeting.","evidence_excerpt":"The Company’s stockholders approved the compensation of our named executive officers for 2025 on an advisory basis, as set forth below:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"},{"claim_id":"ed3dea8bd8521276f7acf097551cafdf2fa74f8d","claim":"Evolent Health, Inc. shareholders approved Amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan at the 2026-06-04 meeting.","evidence_excerpt":"The Company’s stockholders approved the amendment to the Amended and Restated 2015 Omnibus Incentive Compensation Plan, as set forth below:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1628908/000162890826000037/0001628908-26-000037-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-04"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}